Does the negative correlation found in breast cancer patients between plasma melatonin and insulin-like growth factor-I concentrations imply the existence of an additional mechanism of oncostatic melatonin influence involved in defense?

Medical Science Monitor

Volumn 8, Issue 6, 2002, Pages

  Kajdaniuk, Dariusz ^a   Marek, Bogdan ^a   Kos Kudła, Beata ^a   Zwirska Korczala, Krystyna ^a   Ostrowska, Zofia ^a   Buntner, Barbara ^a   Szymszal, Jan ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

IGF; Neoplasm; Pineal gland

Indexed keywords

MELATONIN; SOMATOMEDIN C;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; STATISTICAL ANALYSIS; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; RADIOIMMUNOASSAY;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMAN; INSULIN-LIKE GROWTH FACTOR I; MELATONIN; MIDDLE AGE; RADIOIMMUNOASSAY; HUMANS; MIDDLE AGED;

EID: 0036286778     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors
2. Antocrine and paracrine growth regulation of breast cancer: Clinical implications
3. Insulin-like growth factors and cancer
4. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer
5. IGF system components as prognostic markers in breast cancer
6. Insulinopodobnyczynnik wzrostowy-l: Aspekty patofizjologiczne i kliczne
7. Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation
8. Growth factors and cancer
9. Can all postmenopausal women with a diagnosis of breast cancer benefit tamoxilen treatment?
10. In vivo inhibition of insulin-like growth Factor I gene expression by tamoxifen
11. Perrotta A Insulin-like growth factor-I (1GF-I) and IGF-binding proteins blood serum levels in women with early- and late-stage breast cancer: Mutual relationship and possible correlations with patients' hormonal status
12. Insulin-like growth factor-I receptors and insulin-like growth factor-I activity in human primary breast cancer
13. Plasma insulin-like growth factor-I (IGF-1) concentration in human breast cancer
14. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17beta-estradiol
15. Insulin-like growth factor-I (IGF-I) alters drug sensitivity of H B L 100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs
16. Insulin-like growth factor-I receptor, Its role in cell proliferation, apoptosis, and tumorigenicity
17. Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands
18. Biological and clinical role of angiogenesis in breast cancer
19. Neuropeptide growth factors and cancer
20. Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactin
21. Progestin treatment in the dog. Effects on growth hormone, insulin-like growth factor I and glucose homeostasis
22. Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80- year-old men and women
23. Reduced growth of human breast cancer xenografrs in hosts homozygous for the lit mutation
24. Melatonin modulates growth factor activity in MCF-7 human breast cancer cells
25. Modulation of cancer endocrine therapy by melatonin: A phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone
26. Oncostatic effects of melatonin action - Facts and hypotheses
27. Influence of pineal gland on the growth and spread of melanoma in hamsters
28. Reversal by melatonin of the effect of pinealectomy on tumour growth
29. Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer
30. Role of melatonin in health and disease
31. Endocrinology meets immunology: T lymphocytes as novel targets for melatonin
32. Pineal gland, melatonin and cancer
33. Melatonin and 6-sulphatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: Evidence for reduced pineal activity and relevance of urinary determinations
34. Diminished pineal function coincides with disturbed circadian endocrine rhythmicity in untreated primary cancer patients
35. Serial transplants of DMBA-induced mammary tumors in Fischer rats as model system for human breast cancer
36. Neuroimmununomodulation in cancer patients: Correlations between melatonin and b-endorfin blood levels and T helper/suppressor ratio
37. Stage-dependent depression of melatonin in patients with primary breast cancer: Correlation with prolactin, TSH and steroid receptors
38. Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism
39. Melatonin: A principal neuroimmunoregulatory and anti-stress hormone: Its anti aging effects
40. The immunoneuroendocrine role of melatonin
41. Pineal-opioid system interactions in the control of immunoinflammatory responses
42. High-affinity binding of melatonin by human circulating T lymphocytes (CD4-)
43. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system
44. Melatonin inhibition of MCF-7 human breast-cancer cell growth: Influence of cell proliferation rate
45. Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture
46. Antiproliferative effects of melatonin and CGP 52608
47. Melatonin increases oestrogen receptor binding activity of human breast cancer cells
48. Insulin-like growth factor-I in Syrian hamsters: Interactions of photoperiod, gonadal steroids, pinealectomy, and continuous melatonin treatment
49. Effect of indolamines on beta-endorphin release by rat anterior pituitary cells
50. A clinical study on the relationship between the pineal gland and the opioid system
51. A study on the relationship between the pineal gland and the opioid system in patients with cancer
52. Central adrenergic system does not contribute to morphine-stimulated pineal secretion of melatonin in rats
53. Concentration of hormones and mammotropic factors in blood in premenopausal women with breast cancer after radical mastectomy
54. Influence of adjuvant chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil on plasma insulin-like growth and chosen hormones in breast cancer pre-menopausal patients